285 related articles for article (PubMed ID: 28394010)
21. Effects of combination therapy of statin and N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Park SH; Jeong MH; Park IH; Choi JS; Rhee JA; Kim IS; Kim MC; Cho JY; Sim DS; Hong YJ; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
Int J Cardiol; 2016 Jun; 212():100-6. PubMed ID: 27045874
[TBL] [Abstract][Full Text] [Related]
22. Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy After Coronary Angiography or Percutaneous Coronary Intervention in Patients With Diabetes.
Zhang MM; Lv QZ; Li XY
Am J Ther; 2017; 24(4):e423-e430. PubMed ID: 26308327
[TBL] [Abstract][Full Text] [Related]
23. Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention.
Gu G; Yuan X; Zhou Y; Liu D; Cui W
BMC Cardiovasc Disord; 2019 Jun; 19(1):152. PubMed ID: 31234798
[TBL] [Abstract][Full Text] [Related]
24. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
[TBL] [Abstract][Full Text] [Related]
25. Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction.
Han B; Li Y; Dong Z; Wan Q; Shen H; Li J; Wei M; Shen C
Heart Vessels; 2018 Oct; 33(10):1149-1158. PubMed ID: 29704102
[TBL] [Abstract][Full Text] [Related]
26. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.
Liu Y; Tan N; Zhou YL; Chen YY; Chen JY; Chen J; Luo JF
J Nephrol; 2012; 25(3):332-40. PubMed ID: 21928234
[TBL] [Abstract][Full Text] [Related]
27. Effect of Vigileo/FloTrac System-Guided Aggressive Hydration in Acute Myocardial Infarction Patients to Prevent Contrast-Induced Nephropathy After Urgent Percutaneous Coronary Intervention.
Ling W; Jiang Z; Liu K; Zhang H; Qian Y; Tian J; Zhang Z; Chen Y; Qian G
Am J Cardiol; 2023 May; 195():77-82. PubMed ID: 37018968
[TBL] [Abstract][Full Text] [Related]
28. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
Chong E; Shen L; Poh KK; Tan HC
Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
[TBL] [Abstract][Full Text] [Related]
29. Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.
Hölscher B; Heitmeyer C; Fobker M; Breithardt G; Schaefer RM; Reinecke H
Can J Cardiol; 2008 Nov; 24(11):845-50. PubMed ID: 18987758
[TBL] [Abstract][Full Text] [Related]
30. CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions.
Chou RH; Huang PH; Hsu CY; Leu HB; Huang SS; Huang CC; Chen JW; Lin SJ
J Formos Med Assoc; 2016 Jul; 115(7):501-9. PubMed ID: 26830105
[TBL] [Abstract][Full Text] [Related]
31. Association of contrast-induced nephropathy with bare metal stent restenosis in STEMI patients treated with primary PCI.
Güngör B; Karataş MB; İpek G; Özcan KS; Çanga Y; Onuk T; Keskin M; Hayıroğlu Mİ; Karadeniz FÖ; Sungur A; Öztürk R; Bolca O
Ren Fail; 2016 Sep; 38(8):1167-73. PubMed ID: 27436614
[TBL] [Abstract][Full Text] [Related]
32. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention.
Jurado-Román A; Hernández-Hernández F; García-Tejada J; Granda-Nistal C; Molina J; Velázquez M; Albarrán A; Tascón J
Am J Cardiol; 2015 May; 115(9):1174-8. PubMed ID: 25759106
[TBL] [Abstract][Full Text] [Related]
33. Serum osmolarity as a potential predictor for contrast-induced nephropathy following elective coronary angiography.
Kanbay M; Siriopol D; Ozdogan E; Afsar B; Ertuglu LA; Grigore M; Sag AA; Kuwabara M; Lanaspa MA; Ortiz A; Johnson RJ; Covic A
Int Urol Nephrol; 2020 Mar; 52(3):541-547. PubMed ID: 32008199
[TBL] [Abstract][Full Text] [Related]
34. Gender Difference in the Risk of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention.
Barbieri L; Verdoia M; Nardin M; Marino P; Suryapranata H; De Luca G;
Angiology; 2017 Jul; 68(6):542-546. PubMed ID: 27662891
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
Liang M; Yang S; Fu N; Lu C; Tian F; Xing X; Lin W; Liu J
Catheter Cardiovasc Interv; 2018 Mar; 91(4):742-750. PubMed ID: 29024304
[TBL] [Abstract][Full Text] [Related]
36. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Centola M; Lucreziotti S; Salerno-Uriarte D; Sponzilli C; Ferrante G; Acquaviva R; Castini D; Spina M; Lombardi F; Cozzolino M; Carugo S
Int J Cardiol; 2016 May; 210():4-9. PubMed ID: 26921538
[TBL] [Abstract][Full Text] [Related]
37. Utility of the Logistic Clinical Syntax Score in the Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
Ozturk D; Celik O; Erturk M; Kalkan AK; Uzun F; Akturk IF; Akin F; Yildirim A
Can J Cardiol; 2016 Feb; 32(2):240-6. PubMed ID: 26255218
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
39. Safe Hydration Volume to Prevent Contrast-induced Acute Kidney Injury and Worsening Heart Failure in Patients With Heart Failure and Preserved Ejection Fraction After Cardiac Catheterization.
Bei WJ; Wang K; Li HL; Lin KY; Guo XS; Chen SQ; Liu Y; Yi SX; Luo DM; Chen JY; Tan N
J Cardiovasc Pharmacol; 2017 Sep; 70(3):168-175. PubMed ID: 28525419
[TBL] [Abstract][Full Text] [Related]
40. Risk of contrast-induced nephropathy in patients undergoing complex percutaneous coronary intervention.
Azzalini L; Poletti E; Lombardo F; Laricchia A; Beneduce A; Moscardelli S; Bellini B; Maccagni D; Cappelletti A; Ancona MB; Carlino M; Chieffo A; Colombo A; Montorfano M
Int J Cardiol; 2019 Sep; 290():59-63. PubMed ID: 31005417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
